Sort   by:  
 Page size 
TranscriptomicsElectron acceptor-dependent identification of key anaerobic toluene degraders at a tar-oil contaminated aquifer by Pyro-SIP
Bioavailability of electron acceptors is probably the most limiting factor in the restoration of anoxic, contaminated environments. The oxidation of contaminants such as aromatic hydrocarbons, particularly in aquifers, often depends on the reduction of ferric iron or sulphate. We have previously det...
ORGANISM(S): unidentified 
2011-03-18 | E-GEOD-25449 | biostudies-arrayexpress
Transcriptomics3' mRNA-seq of human Ma-Mel-47 (melanoma) and Panc89 (PDAC) cells treated with the USP7 degraders NK266 and NK250, respectively, for 72 h.
3' mRNA-seq was used to study the effects of USP7 degradation by the degraders NK266 and NK250 on gene expression in a human melanoma and PDAC cell line, respectively.
ORGANISM(S): Homo sapiens 
2026-03-27 | E-MTAB-16302 | biostudies-arrayexpress
GenomicsDNA-SIP ETBE degraders
Stable isotope profiling of ETBE degraders
PRJEB52346 | ENA
Genomicsmethylmercury (MeHg) producers and degraders in acid mine drainage sediments
methylmercury (MeHg) producers and degraders in acid mine drainage sediments Genome sequencing and assembly
PRJNA830440 | ENA
GenomicsHCH degraders
Degraders od hexachlorocyclohexane from environmental samples from Egypt
PRJEB6995 | ENA
GenomicsPAHs and BTEX degraders
PAHs and BTEX degraders Metagenome
PRJNA850664 | ENA
Genomics
hydrocarbon degraders
PRJNA1231502 | ENA
ProteomicsBRD9 degraders CAN-25-5405-ETR1
BRD9 degraders unleash GBAFCHromatin Remodeling Activity in Synovial Sarcoma
ORGANISM(S): Homo sapiens (Human) 
2026-06-23 | PXD079388 | Pride
Brd9 degraders gbaf chromatin 
GenomicsMolecular and Structural Basis of Pan-Resistance to BTK Inhibitors and Degraders
Molecular and Structural Basis of Pan-Resistance to BTK Inhibitors and Degraders
PRJNA1463785 | ENA
ProteomicsDistinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
CDK4/6 inhibitors (CDK4/6i) are effective in metastatic breast cancer, but they have been only modestly effective in most other tumor types. Here we show that tumors expressing low CDK6 rely on CDK4 function, and are exquisitely sensitive to CDK4/6i. In contrast, tumor cells expressing both CDK4 and...
ORGANISM(S): Homo sapiens (Human) 
2022-02-16 | PXD023137 | Pride
Cdk4/6 inhibitors and degraders Cdk6 complex Tumor 
Sort   by:  
 Page size